#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13116	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2418	662.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1569	1569	C	832	C,T,G,A	828,2,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21754	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4020	674.5	0	.	n	.	0	T695C	SNP	695	695	T	1229	1229	C	747	C	747	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21754	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4020	674.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1871	1871	A	952	A	952	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21754	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4020	674.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2505	2505	C	713	C,T	712,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21754	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4020	674.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3131	3131	T	806	T,G	805,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21754	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4020	674.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2579	2579	A	633	A	633	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1910	folP	852	852	100.0	folP.l15.c4.ctg.1	1916	124.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1161	1163	AGC	208;206;204	A;G;C	208;206;204	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4966	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3799	162.8	1	SNP	p	S91F	0	.	.	271	273	TCC	794	796	TCC	179;177;177	T;C;C	179;177;177	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4966	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3799	162.8	1	SNP	p	D95G	0	.	.	283	285	GAC	806	808	GAC	186;187;187	G;A;C	186;187;187	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4966	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3799	162.8	1	SNP	p	D95N	0	.	.	283	285	GAC	806	808	GAC	186;187;187	G;A;C	186;187;187	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1842	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1858	123.7	1	SNP	p	G45D	1	.	.	133	135	GAC	749	751	GAC	210;211;212	G,T;A,C;C	209,1;210,1;212	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1024	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1382	92.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3561	170.7	1	SNP	p	D86N	0	.	.	256	258	GAC	894	896	GAC	222;223;223	G,C;A;C	221,1;223;223	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3561	170.7	1	SNP	p	S87R	0	.	.	259	261	AGT	897	899	AGT	221;225;227	A,C;G;T	220,1;225;227	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3561	170.7	1	SNP	p	S87W	0	.	.	259	261	AGT	897	899	AGT	221;225;227	A,C;G;T	220,1;225;227	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3561	170.7	1	SNP	p	S87I	0	.	.	259	261	AGT	897	899	AGT	221;225;227	A,C;G;T	220,1;225;227	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3561	170.7	1	SNP	p	S88P	0	.	.	262	264	TCC	900	902	TCC	231;230;232	T;C;C	231;230;232	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4000	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3207	155.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1860	1862	GGC	229;228;226	G;G;C,A	229;228;225,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1512	1514	GCA	206;208;206	G;C;A	206;208;206	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1515	1517	ATC	208;209;209	A;T,G;C	208;208,1;209	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1527	1529	GTG	215;216;215	G;T,G;G	215;215,1;215	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1527	1529	GTG	215;216;215	G;T,G;G	215;215,1;215	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2031	2033	ACC	224;226;223	A;C;C	224;226;223	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2085	2087	GCG	216;211;210	G;C,G;G,C	216;210,1;209,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2085	2087	GCG	216;211;210	G;C,G;G,C	216;210,1;209,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2208	2210	GGC	207;209;209	G;G;C	207;209;209	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2217	2219	GGC	209;209;210	G;G;C	209;209;210	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3614	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2864	157.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2235	2237	CCG	219;219;218	C,A;C;G,T,C	218,1;219;216,1,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4984	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3658	169.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2458	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2199	139.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	731	731	C	188	C	188	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	G38E	NONSYN	112	114	GGA	643	645	GAA	215;213;215	G;A,T;A	215;212,1;215	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	S46G	NONSYN	136	138	AGC	667	669	GGC	228;228;228	G;G;C,G	228;228;227,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	673	675	GGA	223;227;226	G;G;A,C	223;226;225,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	790	792	GCT	185;184;183	G;C;T	184;184;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	796	798	AGC	183;183;183	A;G;C	183;183;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	888	889	CG	146;148	C;G	146;148	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	891	893	CAG	145;144;146	C;A;G	145;144;146	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	895	897	AAA	146;144;146	A;A;A	146;144;146	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	958	960	GAA	188;189;190	G;A;A	188;189;190	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	982	984	GCA	199;203;204	G,T;C,T;A	198,1;202,1;204	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1174	1176	ACT	201;200;199	A;C;T	201;200;199	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1183	1185	ATG	196;193;190	A;T,A;G	196;192,1;190	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1297	1299	GCA	176;177;178	G;C;A	176;177;178	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1300	1302	ACG	179;178;177	A;CGGGGG,CGGGG;G	179;173,1;177	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1303	1305	GGG	181;182;184	G;G;G	180;181;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1306	1308	GTT	186;185;183	G;T;T	185;185;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1366	1368	GTA	228;227;227	G;T;A	228;227;227	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1405	1407	ACT	221;218;219	A;C;T,G	221;218;218,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1411	1413	GAT	223;226;226	G;A;T	223;226;226	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1423	1425	CAC	229;232;235	C;A;C	228;232;235	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	1	SNP	p	G120K	1	.	.	358	360	AAG	888	890	CGG	146;148;144	C;G;G	146;148;144	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	1	SNP	p	A121D	1	.	.	361	363	GAC	891	894	CGC	145;146;146	C;G;C	145;146;146	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2418	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	2001	150.6	1	SNP	p	D121N	0	.	.	361	363	GAC	891	894	CGC	145;146;146	C;G;C	145;146;146	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8782	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5307	206.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2217	2219	AAT	236;236;234	A;A;T,G	236;236;232,2	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1246	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1522	102.1	1	SNP	p	V57M	1	.	.	169	171	ATG	760	762	ATG	244;242;234	A;T,A;G,T	244;241,1;232,2	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
